Biological weapons

Cellular and Molecular Life Sciences

Volumn 63, Issue 19-20, 2006, Pages 2193-2195

  Bossi, P ^a   Bricaire, F ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; BRUCELLA; CAUSE OF DEATH; CELL PROLIFERATION; CLOSTRIDIUM BOTULINUM; FRANCISELLA TULARENSIS; HEALTH CARE; HEALTH CARE POLICY; HEALTH HAZARD; HUMAN; MORTALITY; NONHUMAN; PLAGUE; PNEUMONIA; SHORT SURVEY; SMALLPOX; T LYMPHOCYTE; UNITED STATES; YERSINIA PESTIS;

EID: 33750448334     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-006-6307-0     Document Type: Short Survey

References (15)

1. Kortepeter, M. G. and Parker, G. W. (1999) Potential biological weapons threats. Emerg. Infect. Dis. 5, 523-527.
2. Bossi, P., Van Loock, F., Tegnell, A. and Gouvras, G. (2004) Bichat clinical guidelines for bioterrorist agents. Euro Surveill. 9, E1-2.
3. Tegnell, A., Bossi, P., Baka, A., Van Loock, F., Hendriks, J., Wallyn, S. and Gouvras, G. (2003). The European Commission's Task Force on Bioterrorism. Emerg. Infect. Dis. 9, 1330-1332.
4. Morens, D. M., Folkers, G. K. and Fauci, A. S. (2004) The challenge of emerging and re-emerging infectious diseases. Nature 430, 242-249.
5. World Health Organisation. Public health response to biological weapons: WHO guidance (2004). World Health Organisation, Geneva, 2004.
6. National Institute of Allergy and Infectious Diseases. National Biodefense Effort, at: http://www3.niaid.nih.gov/biodefense/about/nbe.htm (accessed May 23, 2006).
7. Centers for Disease Control and Prevention (2000) Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup. MMWR 49 (RR-4), 1-14.
8. Franz, D. R. and Zajtchuk, R. (2000). Biological terrorism: understanding the threat, preparation, and medical response. Dis. Mon. 46, 125-190.
9. Flowers, L. K., Mothershead, J. L. and Blackwell, T. H. (2002) Bioterrorism preparedness. II: The community and emergency medical services systems. Emerg. Med. Clin. North. Am. 20, 457-476.
10. Pappas, G., Akritidis, N., Bosilkovski, M. and Tsianos, E. (2005) Brucellosis. N. Engl. J. Med. 352, 2325-2336.
11. Pappas, G., Papadimitriou, P., Akritidis, N., Christou, L. and Tsianos, E. V. (2006) The new global map of human brucellosis. Lancet Infect. Dis. 6, 91-99.
12. Inglesby, T. V., O'Toole, T., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Friedlander, A. M., Gerberding, J., Hauer, J., Hughes et al. (2002) Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA 287, 2236-2252.
13. Swartz, M. (2001) Current concepts: recognition and management of anthrax-an update. N. Engl. J. Med. 345, 1621-1626.
14. Fenner, F., Arita, I., Jezek, Z. and Ladnyi, I. D. (1988). Smallpox and Its Eradication. Geneva: World Health Organization.
15. Combadiere, B., Boissonnas, A., Carcelain, G., Lefranc, E., Samri A, Bricaire, F., Debre, P. and Autran, B. (2004) Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans. J. Exp. Med. 199, 1585-1593.